Microcap Ledger

Tickers · $GXAI

Gaxos.ai Inc. $GXAI

By Microcap Ledger desk · CIK 0001895618

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Services-Prepackaged Software
Headquarters
Roseland, NJ
Fiscal year end
December 31
Shares outstanding
10,744,634 [10-Q 2026-08-12]
as of 2026-08-11

Sources: [10-K 2026-03-17]

What the company doesAI summary of filing

Gaxos.AI is a technology company that develops AI-powered applications and services across several business areas. The company operates Gaxos Labs, which launches generative AI tools including services for game developers, a text enhancement tool called UnGPT.ai, an image and video creation platform called Art-Gen.AI, and Bible Pray AI for spiritual growth. The company also operates Gaxos Health, an AI-powered health and wellness initiative launched in the third quarter of 2024; RNK Health, a subsidiary formed in September 2024 that provides access to medications, supplements, and wellness products; and Gaxos Gaming, which develops games that incorporate AI and NFT features. The company generates revenue from these product offerings but has a limited operating history, with the filing noting it has only recently generated revenues and has not developed sustainable revenue since inception. [10-K 2026-03-17]

Segments: Gaxos Labs, Gaxos Health, RNK Health, Gaxos Gaming

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$4.27M−$1.93M −$3.58M$1.09M[10-Q 2026-08-12]
FY ended Dec 2025$1.93M−$3.90M −$3.85M$840.5K[10-K 2026-03-17]
FY ended Dec 2024$4.0K−$3.42M −$3.28M$14.40M[10-K 2026-03-17]
Quarterly cash burn
−$1.79M
Cash runway Estimate
~1.8 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-142,870,773[10-Q 2024-11-14]
2025-03-257,123,453[10-K 2025-03-28]
2025-05-137,123,453[10-Q 2025-05-15]
2025-08-137,123,453[10-Q 2025-08-13]
2025-11-137,123,453[10-Q 2025-11-13]
2026-03-2510,219,934[10-K 2026-03-17]
2026-05-1310,219,934[10-Q/A 2026-05-19]
2026-08-1110,744,634[10-Q 2026-08-12]
Shelf registration
S-3 filed 2026-09-11; declared effective 2026-09-21 [S-3 2026-09-11]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-10-01. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-10-018-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-10-01]

More on deficiency notices and uplistings: Listing status desk.

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.